Company profile for Accucaps Industries Limited

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Accucaps is an innovative, research-based pharmaceutical organization that develops and supplies value-added products that leverage our deep roots and expertise in soft gel oral dose delivery. Our passion is the thread within the fabric of our culture that generates value for and enduring partnerships with our customers. From bottom to top, when you chose Accucaps, our actions will demonstrate that our customers’ success is...
Accucaps is an innovative, research-based pharmaceutical organization that develops and supplies value-added products that leverage our deep roots and expertise in soft gel oral dose delivery. Our passion is the thread within the fabric of our culture that generates value for and enduring partnerships with our customers. From bottom to top, when you chose Accucaps, our actions will demonstrate that our customers’ success is our success. At the core of our passion is our ownership of our customers’ outcomes. We act as owners to ensure the success of the outcome. Our customers recognize the value of the Accucaps partnership approach in the delivering of customer outcomes in a way that refreshingly differentiates Accucaps from others. To meet the needs of our growing list of customers, over the past 5 years, Accucaps has invested to: Expand our state-of-the-art market-ready packaging capacity, Double its soft gel manufacturing capacity, Establish an industry leading team of R&D professionals focused solely on the development of products utilizing soft gelatin dosing technology, Establish high-potency product development and commercial production capacity, and Create several new patented products, platform technologies and a range of approaches and capabilities which provides the means to: Go from concept to rapid bench-scale prototype development Improve solubility for BCS Class II/IV molecules Improve bioavailability of lipophilic and poorly permeable compounds Develop hormones, highly potent APIs, cytotoxic compounds and API’s requiring special handling within our high-potency Specialty Products Suite Develop Multi-Phase Capsules (i.e. a capsule containing a liquid phase and a Tablet in Capsule, Capsule in Capsule, etc.) utilizing Accucaps’ proprietary technology, and Expand the value of existing product/molecule assets by developing enhanced-value products – convert tablet to soft gel, faster acting, lower dose, improved performance Our passion has generated a significant shift in our business. A shift that has resulted in: Doubling of our customer base, A dramatic increase in commercial supply value, and More than 40 new: high-potency Rx, conventional Rx and OTC products in our development pipeline. We are proud of our accomplishments and we thank you our customers for enabling Accucaps to continually earn the right to be your partner of choice. For more information on how ‘partnering’ with Accucaps can help you put excellence on the shelf, contact us today

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
2125 Ambassador Drive Windsor, Ontario N9C 3R5
Telephone
Telephone
+1-800-665-7210 / (519) 969-5404
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Catalent Completes Accucaps Acquisition
Catalent Completes Accucaps Acquisition

27 Feb 2017

// DRUG DEVELOPMENT

http://www.drug-dev.com/Main/Current-News/Catalent-Completes-Accucaps-Acquisition-to-Expand-1827.aspx

DRUG DEVELOPMENT
27 Feb 2017

http://www.fiercepharma.com/manufacturing/charles-river-sells-cmo-qs-pharma-to-quotient-clinical

Eric Palmer FIERCE PHARMA
16 Feb 2017

http://www.fiercepharma.com/manufacturing/catalent-beats-revenues-and-earnings-ahead-closing-accucaps-deal

Eric Palmer FIERCE PHARMA
08 Feb 2017
Lonza Bulks up with $5.5B Deal for Capsugel
Lonza Bulks up with $5.5B Deal for Capsugel

16 Dec 2016

// Eric Palmer FIERCE PHARMA

http://www.fiercepharma.com/manufacturing/lonza-bulks-up-5-5b-deal-for-capsugel

Eric Palmer FIERCE PHARMA
16 Dec 2016
Catalent Adding OTC Capsule Maker Accucaps to Global Softgel Network
Catalent Adding OTC Capsule Maker Accucaps to Global Softgel Network

29 Nov 2016

// Dan Stanton IN PHARMATECHNOLOGIST

http://www.in-pharmatechnologist.com/Drug-Delivery/Catalent-adding-OTC-capsule-maker-Accucaps-to-global-softgel-network

Dan Stanton IN PHARMATECHNOLOGIST
29 Nov 2016

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Accucaps Industries Limited and get a quotation

Accucaps Industries Limited is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of G. FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES AT WINDSOR, ONTARIO bulk offered by Accucaps Industries Limited

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty